← FDA Drug Approvals (Drugs@FDA)
DEXTROAMPHETAMINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2019-06-21
Drug application
- FDA Application #
ANDA205077- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEXTROAMPHETAMINE SULFATE
- Generic name
- Dextroamphetamine Sulfate
- Active ingredients
- DEXTROAMPHETAMINE SULFATE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- STRIDES PHARMA
- First approval
- 2019-06-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown